ArticlePublic health challenges2024
Prevalence and risk factors for childhood anemia in Rwanda: Using Rwandan demographic and health survey 2019-2020.
Article in Public health challenges, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Childhood Anemia in Mozambique: A Multilevel Mixed-Effects Analysis of 2011-2022/23 Population-Based Surveys.Healthcare (Basel, Switzerland) · 2025Article
- Prevalence and risk factors for childhood anemia in Rwanda: Using Rwandan demographic and health survey 2019-2020.Public health challenges · 2024Article
- Enhancing iron and zinc bioavailability in maize (Frontiers in nutrition · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Anemia in children is a significant health issue globally, with developing countries, notably Africa, being disproportionately affected. This condition can result in detrimental and irreversible impacts on a child's neurological development. Despite its relevance, research on anemia prevalence and risk factors in Rwandan children aged 6-23 months is limited. Our study aimed to ascertain the prevalence and potential risk factors associated with anemia in this defined population. Methods: This is a cross-sectional study that used secondary data analysis on a weighed sample of 1247 children aged 6-23 months, sourced from the 2019-2020 Rwanda Demographic Health Survey. We used descriptive statistics and binary logistic regression to identify the links between anemia and various factors. Results: The study revealed a high prevalence of anemia at 52.79%. Among anemic children aged 6-23 months, most (52.82%) had mild anemia, 46.12% had moderate anemia, and 1.06% had severe anemia. Key contributors to childhood anemia included maternal anemia (adjusted odds ratio [AOR] = 1.62, 95% confidence intervals (95% CI): [1.11, 2.33]) and history of coughing in the 2 weeks before the survey (AOR = 1.42, 95% CI: [1.12, 1.81]). Vitamin A supplementation and antiparasitic medication were identified as protective factors (AOR = 0.70, 95% CI: [0.50, 0.97]) and (AOR = 0.59, 95% CI: [0.45, 0.77]), respectively. Conclusion: Given the high anemia prevalence among Rwandan children aged 6-23 months, targeted public health interventions are critically needed. A comprehensive strategy throughout the health system is essential for reducing childhood anemia, involving measures such as addressing maternal anemia, managing childhood illnesses, and enhancing existing interventions like vitamin A supplementation and deworming.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.